findmyKOL
Clinical trialNCT02289820CompletedPhase 1Interventional

A Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults

SponsorMedImmune LLCEnrollment363Respiratory Syncytial Virus (RSV)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Research Site

    Orlando, Florida, United States

  • Research Site

    South Miami, Florida, United States

  • Research Site

    Kansas City, Missouri, United States

  • Research Site

    Raleigh, North Carolina, United States

  • Research Site

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Jan 2015
Primary completion
24 Feb 2016
Completion
24 Feb 2016
Last update posted
15 Mar 2018
Registered enrollment
363
Registry id
NCT02289820

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.